GOLGA6L22: A Potential Drug Target and Biomarker (G440243)

Target Name: GOLGA6L22

NCBI ID: G440243

GOLGA6L22

GOLGA6L22: A Potential Drug Target and Biomarker

Golgi are a type of intracellular organ that plays a crucial role in the secretion of proteins and other molecules from cells. The Golgi system is composed of several components, including the transmembrane protein, the cytoplasmic protein, and the pericellular protein. One of the proteins that belong to the Golgi system is GOLGA6L22, which is a member of the Golgin subfamily A. GOLGA6L22 is a unique protein that has been identified as a potential drug target and biomarker.

GOLGA6L22 is a 22-kDa protein that is expressed in most tissues of the body. It is characterized by its ability to interact with various proteins, including the cytoplasmic protein APC (alpha-glucosaminidase P) and the transmembrane protein SNAP (sodium-dependent intracellular antiproteinases). GOLGA6L22 has been shown to play a role in the regulation of intracellular signaling pathways, including the TGF-beta pathway.

One of the key functions of GOLGA6L22 is its ability to interact with APC, a protein that is involved in the degradation of extracellular matrix (ECM) components. The ECM is a complex mixture of carbohydrates, proteins, and other molecules that are produced by cells and is involved in many cellular processes, including cell adhesion, migration, and invasion. GOLGA6L22 has been shown to play a role in the regulation of APC activity, including its ability to inhibit the degradation of ECM components by APC.

In addition to its role in the regulation of APC activity, GOLGA6L22 has also been shown to interact with SNAP, a protein that is involved in the regulation of intracellular signaling pathways, including the TGF-beta pathway. The TGF-beta pathway is a well-known signaling pathway that is involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. GOLGA6L22 has been shown to play a role in the regulation of SNAP activity, including its ability to inhibit the phosphorylation of SNAP by TGF-beta.

GOLGA6L22 has also been shown to play a role in the regulation of cellular signaling pathways that are involved in cell adhesion, migration, and invasion. For example, GOLGA6L22 has been shown to interact with the protein N-cadherin, which is involved in the regulation of cell adhesion. N-cadherin is a transmembrane protein that is characterized by its ability to interact with various intracellular signaling pathways, including the TGF-beta pathway. GOLGA6L22 has been shown to play a role in the regulation of N-cadherin activity, including its ability to inhibit the phosphorylation of N-cadherin by TGF-beta.

In addition to its role in the regulation of intracellular signaling pathways, GOLGA6L22 has also been shown to play a role in the regulation of cellular structure and function. For example, GOLGA6L22 is involved in the regulation of the localization of various intracellular signaling pathways, including the TGF-beta pathway. The TGF-beta pathway is a well-known signaling pathway that is involved in the regulation of cellular processes such as cell growth, differentiation, and inflammation. GOLGA6L22 has been shown to play a role in the regulation of

Protein Name: Golgin A6 Family Like 22

The "GOLGA6L22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA6L22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets